Product Information

VENLAFAXINE HCL ER 75 MG CAP is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0940 per EA under NDC 33342019507. Its NADAC has been published 279 times since Jan 15, 2020.

FDA first approved this application on Oct 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VENLAFAXINE HCL ER 75 MG CAP

Venlafaxine hydrochloride
$0.0940per EA

Strength

75 mg/1

NDC

33342019507

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

4/23/2025

Active Ingredients

VENLAFAXINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204889

FDA Approved

10/5/2017

TE Code

AB

On Market Since

10/6/2017

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE HCL ER 75 MG CAP has been published 279 times since Jan 15, 2020, and over the history we have for it it has declined 42.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0940 per EA
All-time high$0.1646 (Jan 15, 2020)
All-time low$0.0759 (Nov 20, 2024)
Median price$0.1161
Average price$0.1173
Largest weekly change+25.7% (Aug 21, 2024)
Weeks tracked279
Tracking sinceJan 15, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-14.9%

5Y

-24.8%

All

-42.9%

Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Venlafaxine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of VENLAFAXINE HCL ER 75 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 75 MG CAP, manufactured by Macleods Pharmaceuticals Limited, is $0.0940 per EA (NDC 33342019507), effective May 14, 2025.

How has the price of VENLAFAXINE HCL ER 75 MG CAP changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has declined 42.9%. It has been tracked across 279 weekly CMS publications since Jan 15, 2020.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 75 MG CAP?

Since Jan 15, 2020, the NADAC for VENLAFAXINE HCL ER 75 MG CAP has ranged from a low of $0.0759 (Nov 20, 2024) to a high of $0.1646 (Jan 15, 2020), with a median of $0.1161 per EA.

Are there cheaper alternatives to VENLAFAXINE HCL ER 75 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE HCL ER 75 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures VENLAFAXINE HCL ER 75 MG CAP?

VENLAFAXINE HCL ER 75 MG CAP (NDC 33342019507) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.